A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

NCT00392925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: pramlintide acetate 360 mcg
DRUG: metreleptin
DRUG: placebo-pramlintide 600 uL
DRUG: placebo-metreleptin 1 mL
DRUG: Pramlintide acetate 180 mcg

Sponsor

AstraZeneca